Pain Therapeutics receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Filana Therapeutics, Inc (FLNA)
Filana Therapeutics, Inc stock price live, this page displays NASDAQ FLNA stock exchange data. View the FLNA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Filana Therapeutics, Inc real time stock price chart below.
What Is the Filana Therapeutics, Inc Stock Price Today?
The Filana Therapeutics, Inc stock price today is 0.91.
What Is the Stock Symbol for Filana Therapeutics, Inc?
The stock symbol for Filana Therapeutics, Inc is "FLNA."
What Stock Exchange Does Filana Therapeutics, Inc Trade On?
Filana Therapeutics, Inc is listed and trades on the NASDAQ stock exchange.
Is Filana Therapeutics, Inc a Good Stock to Buy?
Determining whether Filana Therapeutics, Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the FLNA quote. (ISIN: US14817C1071)
What Is the Filana Therapeutics, Inc Stock Price Today?
The Filana Therapeutics, Inc stock price today is 0.91.
What Is the Stock Symbol for Filana Therapeutics, Inc?
The stock symbol for Filana Therapeutics, Inc is "FLNA."
What Stock Exchange Does Filana Therapeutics, Inc Trade On?
Filana Therapeutics, Inc is listed and trades on the NASDAQ stock exchange.
Is Filana Therapeutics, Inc a Good Stock to Buy?
Determining whether Filana Therapeutics, Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the FLNA quote. (ISIN: US14817C1071)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.91
0.95
52 wk Range
0.86
4.98
FLNA is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.910.95
52 wk Range
0.864.98
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
FLNA Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
6.50
Upside
+614.29%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Cassava Sciences changes name to Filana Therapeutics- Investing.com
- Pain Therapeutics receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Cassava Sciences changes name to Filana Therapeutics
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 6.50
(+614.29% Upside)
Earnings
Latest Release
Jul 29, 2026
EPS / Forecast
-0.18 / -0.21
Revenue / Forecast
-- / --
Compare FLNA to Peers and Sector
Metrics to compare | FLNA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipFLNAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.0x | −10.3x | −0.4x | |
PEG Ratio | −0.02 | −0.41 | 0.00 | |
Price/Book | 0.7x | 4.0x | 2.6x | |
Price / LTM Sales | - | 2.3x | 3.1x | |
Upside (Analyst Target) | - | 33.6% | 48.3% | |
Fair Value Upside | Unlock | 2.4% | 6.2% | Unlock |
Filana Therapeutics, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is in Phase 3 clinical trial to treat Alzheimer’s disease; and investigational diagnostic product candidate is SavaDx, an early-stage program focused on detecting the presence of Alzheimer’s disease from a small sample of blood. The company was formerly known as Cassava Sciences, Inc. and changed its name to Filana Therapeutics, Inc. in March 2026. The company was incorporated in 1998 and is based in Austin, Texas.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Filana Therapeutics, (FLNA) Stock Price Today?
The Filana Therapeutics, stock price today is 0.91 USD.
What Stock Exchange Does Filana Therapeutics, Trade On?
Filana Therapeutics, is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Filana Therapeutics,?
The stock symbol for Filana Therapeutics, is "FLNA."
What Is the Filana Therapeutics, Market Cap?
As of today, Filana Therapeutics, market cap is 44.12M USD.
What Is Filana Therapeutics,'s Earnings Per Share (TTM)?
The Filana Therapeutics, EPS (TTM) is -0.88.
When Is the Next Filana Therapeutics, Earnings Date?
Filana Therapeutics, will release its next earnings report on Nov 11, 2026.
From a Technical Analysis Perspective, Is FLNA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Filana Therapeutics, Stock Split?
Filana Therapeutics, has split 1 times.
How Many Employees Does Filana Therapeutics, Have?
Filana Therapeutics, has 19 employees.
What is the current trading status of Filana Therapeutics, (FLNA)?
As of Aug 16, 2026, Filana Therapeutics, (FLNA) is trading at a price of 0.91 USD, with a previous close of 0.95 USD. The stock has fluctuated within a day range of 0.91 USD to 0.95 USD, while its 52-week range spans from 0.86 USD to 4.98 USD.
What Is Filana Therapeutics, (FLNA) Price Target According to Analysts?
The average 12-month price target for Filana Therapeutics, is 6.50 USD, with a high estimate of 8 USD and a low estimate of 5 USD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +614.29% Upside potential.
What Is the FLNA Premarket Price?
FLNA's last pre-market stock price is 0.93 USD. The pre-market share volume is 260.00, and the stock has decreased by -0.02, or -2.11%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.